TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,650	70,587	97,673	110,233	255,964	517,387
Market Cap Growth	-45.30%	-27.73%	-11.39%	-56.93%	-50.53%	27.98%
Enterprise Value	29,626	107,353	107,951	136,288	323,257	529,065
Last Close Price	989.00	1582.46	2353.47	2736.28	7885.33	16336.79
PE Ratio	-	-	7.02	-	-	-
PS Ratio	0.82	1.86	2.69	3.96	6.76	15.61
PB Ratio	0.35	0.85	0.93	1.31	2.40	5.66
P/TBV Ratio	0.42	1.10	1.18	1.83	3.35	8.74
P/FCF Ratio	-	-	-	-	-	309.62
P/OCF Ratio	-	57.91	-	-	-	184.59
EV/Sales Ratio	0.68	2.84	2.97	4.90	8.54	15.96
EV/EBITDA Ratio	-	24.20	20.72	623.83	-	229.33
EV/EBIT Ratio	-	-	111.83	-	-	-
EV/FCF Ratio	-24.96	-	-	-	-	316.61
Debt / Equity Ratio	0.33	0.67	0.26	0.36	0.53	0.97
Debt / EBITDA Ratio	5.81	12.55	5.26	138.58	-	38.28
Debt / FCF Ratio	-	-	-	-	-	52.85
Asset Turnover	0.28	0.26	0.28	0.19	0.21	0.21
Inventory Turnover	6.23	5.55	5.57	4.99	6.71	6.12
Quick Ratio	0.87	0.27	0.56	0.47	0.55	0.39
Current Ratio	1.00	0.37	0.95	0.67	0.62	0.44
Return on Equity (ROE)	-33.90%	-28.18%	14.75%	-44.16%	-23.10%	-40.73%
Return on Assets (ROA)	0.50%	-0.03%	0.46%	-1.77%	-1.62%	-0.83%
Return on Invested Capital (ROIC)	1.22%	-0.06%	0.85%	-3.33%	-3.10%	-1.58%
Return on Capital Employed (ROCE)	1.20%	-0.10%	0.90%	-4.80%	-4.20%	-2.20%
Earnings Yield	-93.98%	-37.29%	14.24%	-38.18%	-9.02%	-7.90%
FCF Yield	-3.33%	-5.31%	-5.07%	-2.64%	-1.02%	0.32%
Buyback Yield / Dilution	-140.20%	20.89%	-8.89%	-56.33%	-2.65%	-3.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.